IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50.00% and +6.45%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 Provided by ACCESS Newswire Jun 27, 2025, 5:30:00 AM ...

The tone and dynamic of the 51st IGC sessions and the strategies deployed by delegates were not encouraging. Rather than generate anticipated momentum for IGC’s work on the TK and TCEs text (s), it ...

Epiphone just launched this new Inspired by Gibson Custom 1962 ES-335 Reissue, and I had the fortune to try one out. Read all about it here.

2026 Lexus ES Exterior - Find EV charging stations near you Compared to the 2025 model, the 2026 Lexus ES is 6.5 inches longer overall, and the wheelbase is stretched by 3 inches. These elongated ...

About IGC Pharma's New Advisors: Frank Zaccanelli, a seasoned entrepreneur and former President, General Manager, and minority owner of the Dallas Mavericks, under Perot family's majority ownership.

IGC Pharma's CALMA Phase 2 trial is being conducted in the United States, and Canada, with a goal of enrolling 146 participants. The study aims to evaluate IGC-AD1's potential in reducing agitation in ...

Read our 2026 Lexus ES review for information on ratings, pricing, specs, and features, and see how this sedan performed in our testing.

Backdrop to the 50th WIPO IGC Session At the 50th session of the World Intellectual Property Organization’s Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional ...

All reports on IGC Pharma prepared by analysts represent the views of those analysts and are not necessarily those of IGC Pharma. IGC is not responsible for the content, accuracy, or timelines ...